No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 2, 1998, Pages 231-239

  Takaoka, Atsushi ^a   Nakae, Ichiro ^a   Takahashi, Masayuki ^a   Matsumoto, Tetsuya ^a   Liu, Quan ^a   Mitsunami, Kenichi ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Captopril (CAP); Coronary blood flow; Nitroglycerin (NTG); S Nitrosocaptopril (S NO Cap)

Indexed keywords

ALDOSTERONE; CAPTOPRIL; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; NORADRENALIN; RENIN; S NITROSOCAPTOPRIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG CROSS TOLERANCE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTENSION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALDOSTERONE; ANIMALS; CAPTOPRIL; CORONARY CIRCULATION; CYCLIC GMP; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; FEMALE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; NITRATES; NITRIC OXIDE; NITROGLYCERIN; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; RENIN; VASODILATOR AGENTS;

EID: 0031933540     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199802000-00008     Document Type: Article

References (28)

1. Loscalzo J, Smick D, Andon N, Cooke J. S-Nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets. J Pharmacol Exp Ther 1989;249:726-9.
2. Cooke JP, Andon N, Loscalzo J. S-Nitrosocaptopril. II. Effect on vascular reactivity. J Pharmacol Exp Ther 1989;249:730-4.
3. Amano M, Takahashi M, Kosaka T, Kinoshita M. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide. J Cardiovasc Pharmacol 1994;24:860-6.
4. Shaffer JE, Lee F, Thomson S, Han BJ, Cooke JP, Loscalzo J. The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs. J Pharmacol Exp Ther 1991;256:704-9.
5. Nakae I, Takahashi M, Kinoshita T, Matsumoto T, Kinoshita M. The effects of S-nitrosocaptopril on canine coronary circulation. J Pharmacol Exp Ther 1995;274:40-6.
6. Takahashi M, Nakae I, Amano M, Kinoshita M. Anti-anginal effects of 5-nitroso-captopril to coronary artery and on platelets [Abstract]. J Am Coll Cardiol 1994;23:211A.
7. Crean PA, Ribeiro P, Crea F, Daview GJ, Ratcliffe D, Maseri A. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Am Heart J 1984;108:1494-500.
8. Katz RJ, Levy WS, Buff L, Wasserman AG. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors. Circulation 1991;83:1271-7.
9. Lawson DL, Nichols WW, Mehta P, Mehta JL. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity. J Cardiovasc Pharmacol 1991;17:411-8.
10. Meredith IT, Alison JF, Zhang F-M, Horowitz JD, Harper RW. Captopril potentiates the effects of nitroglycerin in the coronary vascular bed. J Am Coll Cardiol 1993;22:581-7.
11. Matsumoto T, Takahashi M, Nakae I, Kinoshita M. Vasorelaxing effect of 5-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin. J Pharmacol Exp Ther 1995;275:1247-53.
12. Miyauchi N, Takahashi M, Fujioka H, Kinoshita M. Dissociation of hemodynamic and coronary arterial tolerance to nitroglycerin in dogs. J Cardiovasc Pharmacol 1993;21:767-73.
13. Schwartz JS, Bache RJ. Effect of anesthesia on reactivity of large coronary arteries in the dog. J Cardiovasc Pharmacol 1987; 9:87-90.
14. Muiesan ML, Agabiti-Rosei E, Romanelli G, et al. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related sympathetic and renin-angiotensin-aldosterone activity. Eur Heart J 1992;13:15-21.
15. - formation. Biochem J 1993;292:545-50.
16. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981;27:1922-5.
17. Tsutamoto T, Kanamori T, Wada A, Kinoshita M. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 1992;20:541-6.
18. Altman JD, Kinn J, Duncker DJ, Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 1994;28:119-24.
19. Needleman P, Johnson EM. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184:709-15.
20. Feelisch M, Keim M. Biotransformation of organic nitrates to nitric oxide vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1991;180:286-93.
21. Abrams J. Interactions between organic nitrates and thiol groups. Am J Med 1991;91(suppl 3C):106-12S.
22. Colucci WS, Williams GH, Alexander RW, Braunwald E. Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. Am J Med 1981;71:89-99.
23. Parker JD, Farrel B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 1991;84:2336-45.
24. van Gilst WH, van Wijngaarden J, Scholtens E, de Graeff PA, de Langen CDJ, Wesseling H. Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism? J Cardiovasc Pharmacol 1987;9(suppl 2):S31-6.
25. Wiemer G, Schölkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
26. Mombouli J-V, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991;18(suppl II):II-22-9.
27. Muiesan ML, Boni E, Castellano M, et al. Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris. Eur Heart J 1993;14:1701-8.
28. Liu Q, Nakae I, Tsutamoto T, Takaoka A, Kinoshita M. In vivo vasodilatory action of atrial natriuretic peptides in canine coronary circulation. Jpn Circ J 1996;60:300-10.